ISBA 2010 World Meeting

描述(申请人提供)：ISBA2010年世界会议(http://www.bayesian.org/events/isba2010/))将于2010年6月3-8日在西班牙贝尼多姆举行。这次会议将与第九届巴伦西亚贝叶斯统计问题国际会议同时举行。 国际贝叶斯分析学会(ISBA，www.bayesian.org)成立于1992年。其使命是促进贝叶斯统计理论和方法的发展和应用，这些理论和方法有助于解决科学、工业和政府中的理论和应用问题。其使命是促进贝叶斯统计理论和方法的发展和应用，这些理论和方法有助于解决科学、工业和政府中的理论和应用问题。在过去的10年里，贝叶斯方法越来越多地被用于生物医学研究问题的推理中。通过赞助和组织会议和其他活动，ISBA为那些对贝叶斯推理及其应用感兴趣的人提供了一个焦点。 总的来说，这次会议的目的是将国际上在统计和其他领域的不同调查人员聚集在一起，他们制定和使用贝叶斯方法，分享最新的调查结果，并提出新的、具有挑战性的问题，供国际社会解决。会议组织者希望提供一个促进思想交流和交叉滋养的场所，欢迎年轻研究人员，并促进合作和互动。 所有申请的拨款都将用于介绍与癌症研究相关工作的新研究人员的旅费。至少50%的人将支持女性和代表性不足的少数族裔。将组织这次会议，以积极鼓励新的研究人员和代表性不足的群体参加，并为发起国际合作提供机会。我们将通过确定和邀请合适的合格人员，以及计划中的会议计划中的各种活动来实现这一目标。 公共卫生相关性：会议预计将大大推进贝叶斯生物统计学和生物信息学的研究，从而帮助患者更快地获得更好和更个性化的治疗方案。例如，贝叶斯临床试验设计中的新方法回应了临床研究中对提高效率和伦理标准的需求。整合蛋白质表达数据、途径信息和临床数据对于让患者和临床医生为特定患者选择最有希望的治疗方案至关重要。

DESCRIPTION (provided by applicant): The ISBA 2010 World Meeting (http://www.bayesian.org/events/isba2010/) will be held in Benidorm, Spain, June 3-8, 2010. The conference will be held in conjunction with the Ninth Valencia International Meeting on Bayesian Statistics. The International Society for Bayesian Analysis (ISBA, www.bayesian.org) was established in 1992. Its mission is to promote the development and application of Bayesian statistical theory and methods useful in the solution of theoretical and applied problems in science, industry and government. Its mission is to promote the development and application of Bayesian statistical theory and methods useful in the solution of theoretical and applied problems in science, industry and government. Over the last 10 years Bayesian methods have been increasingly used in inference for biomedical research problems. By sponsoring and organizing meetings and other activities ISBA provides a focal point for those interested in Bayesian inference and its applications. In general terms, the purpose of the conference is to bring together the diverse international community of investigators in statistics and in other areas who develop and use Bayesian methods to share recent findings and to present new and challenging problems to be addressed by the community. Meeting organizers hope to provide a venue that facilitates the exchange of ideas and cross-fertilization, is welcoming to young researchers, and promotes collaborations and interactions. All of the requested grant will go towards travel expenses of new researchers who present work related to cancer research. At least 50% will support women and underrepresented minorities. The meeting will be organized to actively encourage participation of new researchers and underrepresented groups, and to provide opportunities for the initiation of international collaborations. We will achieve this goal by identifying and inviting appropriate qualified individuals, and by a variety of activities in the planned conference program. PUBLIC HEALTH RELEVANCE: The conference is expected to significantly advance research in Bayesian biostatistics and bioinformatics and thereby help patients get faster access to better and more personalized treatment options. For example, novel approaches in Bayesian clinical trial design respond to the need for increased efficiency and ethical standards in clinical studies. Integrating protein expression data, pathway information and clinical data is critical to allow patients and clinicians to select the most promising treatment options for specific patients.